In this respect, CBL0137, a non-genotoxic anti-cancer small molecule belonging to the curaxins family of drugs [14, 15] may be a particularly attractive drug to improve the treatment of MYC-overexpressing TNBCs. The gene discussed is MYC; the disease is cancer.